Healthquad Capital Advisors Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 33.49%
(FY 2023)
- Profit 14.28%
(FY 2023)
- Ebitda 14.49%
(FY 2023)
- Net Worth 88.41%
(FY 2023)
- Total Assets 71.84%
(FY 2023)
About Healthquad Capital Advisors
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Thakur, Charles Janssen, Amit Varma, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999DL2019PTC352056
- Company No.
352056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Healthquad Capital Advisors?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Thakur  | Director | 02-Jul-2019 | Current |
Charles Janssen  | Director | 13-Nov-2019 | Current |
| Amit Varma | Director | 13-Nov-2019 | Current |
| Francois Borchgrave | Additional Director | 21-Mar-2024 | Current |
Financial Performance of Healthquad Capital Advisors.
Healthquad Capital Advisors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.49% increase. The company also saw a substantial improvement in profitability, with a 14.28% increase in profit. The company's net worth Soared by an impressive increase of 88.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healthquad Capital Advisors?
In 2023, Healthquad Capital Advisors had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Panacea Medical Technologies Private LimitedActive 25 years 9 monthsCharles Janssen is a mutual person
Neonatal Care & Research Institute Private LimitedActive 13 years 4 monthsCharles Janssen is a mutual person
Ibof Investment Management Private LimitedActive 15 years 9 monthsSunil Thakur and Amit Varma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Healthquad Capital Advisors?
Unlock and access historical data on people associated with Healthquad Capital Advisors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healthquad Capital Advisors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healthquad Capital Advisors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
